Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Atara Biotherapeutics (ATRA) Interest Expenses (2022 - 2025)

Historic Interest Expenses for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to $909000.0.

  • Atara Biotherapeutics' Interest Expenses fell 2316.15% to $909000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 1799.33%. This contributed to the annual value of $4.6 million for FY2024, which is 1267.74% down from last year.
  • Atara Biotherapeutics' Interest Expenses amounted to $909000.0 in Q3 2025, which was down 2316.15% from $972000.0 recorded in Q2 2025.
  • Over the past 5 years, Atara Biotherapeutics' Interest Expenses peaked at $1.4 million during Q3 2023, and registered a low of $4000.0 during Q1 2022.
  • In the last 4 years, Atara Biotherapeutics' Interest Expenses had a median value of $1.0 million in 2024 and averaged $878066.7.
  • Per our database at Business Quant, Atara Biotherapeutics' Interest Expenses surged by 3330000.0% in 2023 and then crashed by 2316.15% in 2025.
  • Atara Biotherapeutics' Interest Expenses (Quarter) stood at $117000.0 in 2022, then skyrocketed by 905.13% to $1.2 million in 2023, then decreased by 13.52% to $1.0 million in 2024, then decreased by 10.62% to $909000.0 in 2025.
  • Its last three reported values are $909000.0 in Q3 2025, $972000.0 for Q2 2025, and $1.0 million during Q1 2025.